London, February 9, 2026, 08:35 GMT — Regular session
- Unilever shares slipped at the open in London after Deutsche Bank downgraded the stock to “hold” from “buy”.
- The broker stuck with its 5,150p target price—still under where the stock most recently traded.
- Unilever’s results update lands later this week, and investors are watching for any read on volume trends or signals for guidance.
Shares of Unilever slipped Monday, losing 0.7% to 5,214 pence by 0838 GMT, after Deutsche Bank lowered its rating, pointing to what it called a stretched valuation following the stock’s recent rally. Unilever traded between 5,200 and 5,234 pence, down from a Friday close of 5,250 pence.
This downgrade stands out—Unilever’s back in the crowded defensive camp, with shares fully pricing in a neat earnings print. That leaves little room for error: even minor slips in volumes or margins could hit the stock harder than typical, steady sales or not.
Deutsche Bank’s Tom Sykes downgraded Unilever to “hold” from “buy” after the stock pushed past the bank’s 5,150p target, according to a note from the firm. Sykes flagged that Unilever is now sitting at roughly 19 times forward 12-month earnings—a metric that pits price against projected profits—and that’s a 19% premium to the broader market. “The valuation no longer supports a ‘buy’ recommendation,” he wrote. Investing.com
Deutsche Bank’s target price puts the stock only a touch higher than its own fair value estimate. That’s intentional: there’s little room to maneuver if the next set of numbers is just okay.
Unilever, which makes Dove soap and Hellmann’s mayonnaise, has relied on price hikes and mix shifts lately, with some consumers opting for cheaper alternatives. Now, investors are eyeing whether unit sales will start to drive growth as price increases ease.
The implications stretch to the rest of Europe’s staple names. Funds tend to group Nestlé and Reckitt Benckiser alongside Unilever—they’re all seen as “steady cash flow” bets. So when Unilever’s valuation gets thrown into question, that ripple can hit the whole sector quickly, especially with these stocks trading in lockstep.
The risk is clear enough: if the stock keeps floating past target prices ahead of results, another broker downgrade could easily show up, especially if management adopts a more cautious tone. Not a disaster, just a duller outcome — steady company, but a stock that loses its momentum.
Still, a strong outlook with clear margin guidance can outweigh valuation chatter—at least for now—especially if the broader market stumbles and investors swing toward defensive names. That’s the balancing act in this trade.
Unilever’s event calendar pegs its fourth-quarter and full-year 2025 earnings release for Feb. 12, with a slot at the CAGNY consumer conference on Feb. 17.
